Diagnostic and Therapeutic Approach to Kidney Patient S. Ossareh- M.D. HKC-IUMS S. Ossareh- M.D. HKC-IUMS.

Slides:



Advertisements
Similar presentations
Antenatal care Dr. Rekha Dutt Associate Professor Department of PSM ,
Advertisements

IC5.5.5 Formulae of salts © Oxford University Press 2011 Formulae of salts How to work out the formulae of salts.
MINERAL AND BONE DISORDERS IN CHRONIC KIDNEY DISEASE PEDRAM.AHMADPOOR SHAHID BEHESHTI MEDICAL UNIVERSITY.
The kidney,chronic kidney disease and WAGR kidney disease
This lecture was conducted during the Nephrology Unit Grand Ground by Consultant under Nephrology Division under the supervision and administration of.
Hyperparathyroidism in Chronic Kidney Disease 醫五 李政霆.
Anemia in chronic kidney disease
Agents Used to Treat Anemias. Anemia Decreased number of circulating red blood cells Decreased hemoglobin = decreased oxygen capacity Many causes. 22.
Chronic Kidney Disease Workshop Maarten Taal Department of Renal Medicine Derby City General Hospital Derby Nephrology Research.
Minimal versus Optimal Care Chronic Renal Failure Omar EL khashab Professor of Renal Medicine Cairo University.
Benign Prostatic Hyperplasia. BPH  Benign increase in size of prostate  Hyperplasia of stromal and epithelial cells  Nodules.
Intravenous Iron Supplementation and Chronic Kidney Disease Chloe Bierbower December 2, 2013.
Parenteral nutrition in neonate. Goals minimizes weight loss improves growth and neurodevelopmental outcome reduce the risk of mortality and NEC.
Chronic Kidney Disease: A Silent Epidemic (Case Review) Naima Ogletree, MSN, APRN, BC Nephrology & Hypertension Henry Ford Health System.
Bones, Calcium, and Osteoporosis. Bone Bone is living, constantly remodeled Reservoir of Calcium – Calcium levels of blood take precedence over bone levels.
Iron supplements Prepared by: AbdulRahman I. Bin Muhanna.
Antenatal Care: Interventions
Diseases of the Renal System KNH 413. CKD - Renal Replacement Therapy Hemodialysis (HD) or Peritoneal Dialysis (PD) Type based on underlying kidney disease.
Parenteral Nutrition Designing the Solution Mark H. DeLegge, MD, FACG, AGAF, FASGE Digestive Disease Center Medical University of South Carolina.
Chronic renal Failure Dr. Jumana Albaramki.
Dr. Sham Sunder. Kidney damage for >= 3months, as defined by structural / functional abnormalities of kidney with or without decreased GFR, and manifest.
Jolanta Malyszko, MD Department of Nephrology and Transplantology
Diabetes and Kidney. Diabetic Kidney Normal Kidney.
NYU Medical Grand Rounds Clinical Vignette Phillip Joseph, MD, PGY-2 September 25 th, 2013 U NITED S TATES D EPARTMENT OF V ETERANS A FFAIRS.
Common Laboratory Tests. Let’s look at some nuances of 3 of most commonly ordered lab tests CBC (Complete Blood Count) BMP (Basic Metabolic Panel) Coagulation.
An interesting case of ARF Prof.S.Shivakumar unit R.Anitha, MD PG.
Biochemical Test Serum Calcium
CASE 5 54 yo man HIV positive in 2001 Immune Thrombocytopenia Chronic G1a Hepatitis C Crack use daily Normotensive.
Tertiary hyperparathyroidism & postoperative hypocalcemia Brock Lanier, M.D. MCV/VCU Department of Surgery M&M 12 April
Scenario 10.1 Digoxin Overdose. ECG CT Head Radiology Preliminary Read: Normal.
1 Scenario 10.3 Sympathomimetic Overdose. 2 ECG 3 CT Head Radiology Preliminary Read: Normal.
Scenario 10.2 Opioid Overdose. ECG CT Head Radiology Preliminary Read: Normal.
Lee, Lucero, Macalintal, Magallanes, Maningas, Ombao, Pacifico.
Chronic Kidney Disease SERVICE 6. Chronic Kidney Disease Stages 4-5 (GFR
BMP Date: McIntyre, Kim MRN Time : LabValueReference Range Glucose125 mg/dL mg/dL Calcium9.8 mg/dL8.9 – 10.3 mg/dL Potassium3.5 mEq/L3.6.
The graph is based on data submitted to the WHO as of June Global Prevalence of Hepatitis C Virus.
NYU Medical Grand Rounds Clinical Vignette Justin Simmons, M.D. Class of /27/2012 U NITED S TATES D EPARTMENT OF V ETERANS A FFAIRS.
2-4. Estimated Renal Function Estimated GFR = 1.8 x (Cs) x (age) Cockcroft-Gault eq. – Estimated creatine clearance (mL/min) = (140 – age x body weight,
Management of chronic kidney disease
PROTEINURIA DR HEDAYATI. INTRODUCTION  URINARY PROTEIN > 150mg/day  More than 1 time  ↑ capillary permeability.
Table 1. Clinical characteristics of subjects Mean ± s.d. n1363 Age (years)55.6 ± 14.1 Genders, % Males49.1 Females50.9 Diabetes, %44.9 Hypertension, %14.0.
Case 2 A 23-year old Indian young man Homozygous Beta-Thalassemia Major Diagnosed at the age of 6 months. On regular transfusion every 4 weeks since that.
Interpreting Laboratory Tests Mesa Community College NUR 152.
Scenario 3.1 Supraventricular Tachycardia 1. Rhythm Strip 2.
Essential Elements Sept 29,  So you are made of elements!! You are made of matter…
Medical Directorate, National Kidney Foundation, Singapore
Cost conscious project: Microcytic anemia
Diseases of the Renal System
LAB 1 URINALYSIS Naseem AL-Mthray.
Multimorbidity and diabetes - what to do?
Progressive Liver Failure following Gastric Bypass
Luisa Sandri, MD, and Martino Marangella, MD
Department of Nephrology- Ain Shams University, Cairo, Egypt
Laboratory Diagnostic Testing
Laboratory Investigations
Clinical approach in Hematology
GYNAECOLOGY SCREENING 1
Protocol for the management of adult patients with DKA
هوالشافی دکتر مریم دهقان 91/8/6.
Diseases of the Renal System
Diseases of the Renal System
Renal Disease Filtration, glomeruli generate removal ultrafiltrate of the plasma based on size and charge of molecules End products include urea, creatinine,
Diseases of the Renal System
CKD Complications By Alaina Darby.
Phosphorus Nutrition and the Treatment of Osteoporosis
Protocol for the management of adult patients with DKA
Volume 74, Pages S88-S93 (December 2008)
Diseases of the Renal System
Approach to anemia.
Multimorbidity and diabetes - what to do?
Presentation transcript:

Diagnostic and Therapeutic Approach to Kidney Patient S. Ossareh- M.D. HKC-IUMS S. Ossareh- M.D. HKC-IUMS

Nephrotic Syndrome/GN Lab: –CBC, ESR –BUN, Cr, Na, K (daily?!!) –PPD –VDRL –Lipid profile –FBS? –Uric acid –Protein, Albumin –HBsAg, HCV Ab, HIV Ab –Immunologic: ANA, ANCA, C3, C4, CH50,antiGBM Ab? –Urinalysis, Urine sediment –24 hour urine collection for protein, creatinine –PTT, PT Sonography KUB Lab: –CBC, ESR –BUN, Cr, Na, K (daily?!!) –PPD –VDRL –Lipid profile –FBS? –Uric acid –Protein, Albumin –HBsAg, HCV Ab, HIV Ab –Immunologic: ANA, ANCA, C3, C4, CH50,antiGBM Ab? –Urinalysis, Urine sediment –24 hour urine collection for protein, creatinine –PTT, PT Sonography KUB

ESRD patients

Paraclinic LAB: –CBC,ESR –BUN, Cr (daily?!!) –Na, K (daily?!!) –Ca, P, ALP,PTH –Lipid profile –Fe, Ferritin,TIBC –Retic, Coombs,S/E, –HBsAg, HCV Ab, HIV Ab –Sonography X-Rays as needed LAB: –CBC,ESR –BUN, Cr (daily?!!) –Na, K (daily?!!) –Ca, P, ALP,PTH –Lipid profile –Fe, Ferritin,TIBC –Retic, Coombs,S/E, –HBsAg, HCV Ab, HIV Ab –Sonography X-Rays as needed

Erythropoetin (Eprex, PD Poetin, Epocin) Hb/Hct goal: –11/33% for women –12/36% for men & post-menopausal women Start Eprex with unit/kg/wk Hb>13 → Reduce Eprex dose Hb> 13.5 → Stop Eprex for 1 month Hb/Hct goal: –11/33% for women –12/36% for men & post-menopausal women Start Eprex with unit/kg/wk Hb>13 → Reduce Eprex dose Hb> 13.5 → Stop Eprex for 1 month

Iron supplement (Venofer, ferrous sulfate) Iron status goal: –Ferritin> 200 and Fe/TIBC> 20% Give IV Venofer 300 mg/wk till you reach the goal Then reduce Venofer dose to 100 mg/wk to keep iron profile within the expected range If ferritin > 500 → reduce Venofer dose If ferritin > 800 &/or Fe/TIBC> 50% → Stop Venofer Iron status goal: –Ferritin> 200 and Fe/TIBC> 20% Give IV Venofer 300 mg/wk till you reach the goal Then reduce Venofer dose to 100 mg/wk to keep iron profile within the expected range If ferritin > 500 → reduce Venofer dose If ferritin > 800 &/or Fe/TIBC> 50% → Stop Venofer

Calcium supplement (Calcium Carbonate, Ca-D) Goal: Keep Ca between 8.4 to 9.5 mg/dl Maximum maintenance dose of Ca: 2 grams of elemental Calcium Keep P between mg/dl with grams of elemental Calcium Carbonate P < 4 mg/dl → CaCO3 between meals Goal: Keep Ca between 8.4 to 9.5 mg/dl Maximum maintenance dose of Ca: 2 grams of elemental Calcium Keep P between mg/dl with grams of elemental Calcium Carbonate P < 4 mg/dl → CaCO3 between meals

Calcium supplement (Calcium Carbonate, Ca-D) P: mg/dl → CaCO3 3 tabs/day (with meals) P:5.5-7 mg/dl → CaCO3 4-6 tabs/day for a limited period (with meals) P > 7 mg/dl or Ca  P >55 → Stop Calcium and use Al(OH)3 for a limited period (30 ml tid for 3-4 weeks) P: mg/dl → CaCO3 3 tabs/day (with meals) P:5.5-7 mg/dl → CaCO3 4-6 tabs/day for a limited period (with meals) P > 7 mg/dl or Ca  P >55 → Stop Calcium and use Al(OH)3 for a limited period (30 ml tid for 3-4 weeks)

Rocaltrol (Calcitriol) If P < 5.5 mg/dl, and Ca < 9.5 and Ca  P <55 start Rocaltrol to keep PTH level between pg/ml PTH: → 2-6 pearls/qod PTH: → 4-16 pearls/qod PTH> 1000 → pearls/qod If P < 5.5 mg/dl, and Ca < 9.5 and Ca  P <55 start Rocaltrol to keep PTH level between pg/ml PTH: → 2-6 pearls/qod PTH: → 4-16 pearls/qod PTH> 1000 → pearls/qod

Vitamin Supplements Folic Acid: 5 mg Bid B-Complex: 1 tab/ day B6: 1 tab/day Folic Acid: 5 mg Bid B-Complex: 1 tab/ day B6: 1 tab/day